CN100344747C - Sulfated NF1 granulose-anti-AIDS medicine and its preparing method - Google Patents

Sulfated NF1 granulose-anti-AIDS medicine and its preparing method Download PDF

Info

Publication number
CN100344747C
CN100344747C CNB021485216A CN02148521A CN100344747C CN 100344747 C CN100344747 C CN 100344747C CN B021485216 A CNB021485216 A CN B021485216A CN 02148521 A CN02148521 A CN 02148521A CN 100344747 C CN100344747 C CN 100344747C
Authority
CN
China
Prior art keywords
granulose
sulfation
sulfated
polysaccharide
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021485216A
Other languages
Chinese (zh)
Other versions
CN1473926A (en
Inventor
陈曦
陈涛
陈浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University
Original Assignee
Nanjing University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University filed Critical Nanjing University
Priority to CNB021485216A priority Critical patent/CN100344747C/en
Publication of CN1473926A publication Critical patent/CN1473926A/en
Application granted granted Critical
Publication of CN100344747C publication Critical patent/CN100344747C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention belongs to the technical field of biologic pharmacy. Based on the patent 'Purificationn and utilization of distilled grains', Fengwei mushroom NF1 strains are screened and cultured; fermentation liquid is obtained in a distilled grain culture medium and via liquid submerged fermentation, separated and purified to obtain NF1 polysaccharide which is sulfated into sulfated NF1 polysaccharide further filled in enteric capsules to obtain an anti-AIDS medicine in the form of sulfated NF1 polysaccharide enteric capsules. The LD50 acute toxicity test result is 10007 mg/kg, extracorporeal detection proves the inhibiting rate of 94.02 % for HIV-RT (reverse transcriptase activity), and oral intracorporeal detection probes treating effect on AIDS patients with attack symptoms.

Description

Sulfation NF 1Granulose---anti-acquired immunodeficiency syndrome drug and preparation method thereof
One, technical field
The invention belongs to biological pharmacy technical field.
Two, background technology
(acquired immunodeficiency syndrome AIDS) is the disease that is called human immunodeficiency virus (human immunodeficiency virus HIV) infection and is suffered from by a kind of to acquired immune deficiency syndrome (AIDS).Blood examination HIV positive person then is considered as HIV the infected.After human body was infected by HIV, it had attacked the CD among the t lymphocyte subset group in the body 4And CD 8, CD 4Sum is less than 200~500/mm 3, CD 4/ CD 8Less than 1, thereby destroyed the immunity system of human body, therefore to other bacterium and the infection of virus have no resistibility and suffer from various symptoms disease (as lose weight, be in a cold sweat in fever, night for a long time, fash, diarrhoea, health are tired, lymph enlargement etc., what have suffers from dementia because of brain cell is subjected to the HIV damage), if can in time treat, then can prolong life,, then cause death as untimely treatment.
Over year, sulfated polysaccharides at home and abroad is subject to people's attention as the new anti-AIDS medicine of a class surplus in the of nearly ten.It is a class chemical structure complexity, and biological activity is various, the biologically active substance of structure activity relationship distinctness.
Sulfated polysaccharides has the adhesion of interference HIV to the host target cell, suppress the antigenic expression of HIV, suppress plasmodial formation, the activity that suppresses hiv reverse transcriptase, biological activitys such as raise immunity, the sulfate radical quantity of being hung on these biological activity degree and its polysaccharide is relevant, also relevant with the space structure of sulfated polysaccharides.Except the side effect of blood coagulation resisting function, find no new side effect so far.
Abroad, the xylan sulfuric ester of former federal republic of germany Bayer in 1987 and Hoechst company joint research and development synthetic, after this U.S.'s artificial synthetic piperylene sulfuric ester and sulfation β-1, the 3-D dextran is clinic trial all, all obtained satisfied result, except that blood coagulation resisting function, do not find new side effect.At home, Chinese Academy of Sciences's Shanghai medicine the side for many years, Xiang Daobin etc. has deep research to sulfated polysaccharides, but do not see the report that is useful on the treatment acquired immune deficiency syndrome (AIDS) so far.
Three, summary of the invention
The objective of the invention is to develop a kind of medicine that can prevent and treat acquired immune deficiency syndrome (AIDS).
(patent No.: on the basis 85 1 04057.8), Pleurotus sajor-caju NF is cultivated in screening in patent of invention " purification of vinasse with utilize method " 1Bacterial strain is by " China Committee for Culture Collection of Microorganisms, common micro-organisms " center " preservation (NF 1The preserving number of bacterial strain is CGMCC NO.0852, and preservation date is on December 9th, 2002), as substratum, inoculate NF with vinasse 1Bacterial strain through the liquid submerged fermentation engineering method, obtains fermented liquid, and separation, purifying obtain NF from fermented liquid 1Granulose detects its sugar degree with grace ketone method, and its yield is 2g/1000ml, and detecting its major ingredient through analytic centre of Nanjing University infrared spectra is β-1, and 3-dextran (See Attachment 1) obtains sulfation NF with its sulfonation reaction 1Granulose, according to C.R.Ricketts, " BiochemistryJournal " Vol.51 report is identified its degree.With sulfation NF 1Granulose pours into enteric coated capsule, becomes sulfation NF 1The granulose enteric coated capsule is the medicine that prevents and treat acquired immune deficiency syndrome (AIDS).Free from environmental pollution in the whole process of preparation, need not additional environmental protection abatement equipment.
Sulfation NF 1The granulose capsule, through Jiangsu Province's drug abuse test institute, its result of the acute toxicity test of mouse oral administration is LD 50=10007mg/kg, visual inspection, all internal organs show no obvious abnormalities (seeing Appendix two).Through the Chinese Academy of Medical Sciences, China Concord Medical Science University, Viral Laboratory, Institute of Medicinal Biological Technique, prominent domestic virusology expert Chen Hongshan researcher's design, check, this medicine (NFS 1) be 94.02% to the inhibiting rate of HIV-1RT (reversed transcriptive enzyme), the NFS that does simultaneously 2, because of the relative NFS of sulfur-bearing acid group amount 1Few, its inhibiting rate is 71.63% (seeing Appendix three).Through Kunming, Yunnan Province property CDC to the oral sulfation NF of 5 routine AIDS patients (volunteer) 1Granulose enteric coated capsule (its dosage is: 0.3g/ grain, 5/time, 2 times/day), 6 days by a definite date, and carry out CD in its oral front and back 4And CD 8Detection, its result shows that this medicine has result of treatment (seeing Appendix four) to the frank patient of AIDS.
The prepared sulfation NF of the present invention 1The raw material of granulose is vinasse, uses liquid submerged fermentation method, and whole preparation process is simple relatively, so cost is low, and Zhi Bei medicine valency is also cheap relatively thus.And the domestic and international medicine of preparation anti-AIDS commonly used, with extracting method in artificial synthesis and the brown alga etc., its technology relative complex, so the medicine high price is expensive.
Also because of preparation sulfation NF 1The raw material of granulose and method are with different both at home and abroad, so the space structure of its major ingredient also can be different, and according to the structure activity relationship principle of sulfated polysaccharides, the effect of this pharmacological agent acquired immune deficiency syndrome (AIDS) also can be with different both at home and abroad.
Sulfation NF 1Granulose can further be made deep development, studies show that sulfation NF according to we are existing 1That granulose can prepare is hypoglycemic, the raw material of reducing blood-fat and treatment liver cancer medicine.
Four, specific embodiments
Get 14 kilograms of sucrose, 2 kilograms of Semen Maydis powder, wheat bran adds Ca (OH) for 5 kilograms 2Auxiliary materials and mixing is transferred about PH to 6, and said mixture is added in one ton of fermentor tank after empty having disappeared, and pressure is 15 kilograms when real disappearing, and temperature is 125 ℃, last 40 minutes after, when jar temperature drop to 30 ℃, add Pleurotus sajor-caju NF 1Bacterial strain, its weight is about 100 kilograms liquid spawn, and making fermentation volume is 1 ton, and through temperature control to 30 ℃, pressure is 0.5 normal atmosphere, promptly finishes through fermentation in 3 days.Emit fermented liquid from jar, after filtration, obtain residue (comprising mycelium), make feed and sell, remaining liquid is condensed into 10% of original volume through decompression, adds in this concentrated solution then that alcohol precipitation separates, purifying obtains NF 1Granulose detects polysaccharide content with grace ketone method.This polysaccharide is obtained sulfation NF with chlorsulfonic acid-pyridine method sulfonation reaction method (the unnecessary pyridine entry of sulfonation reaction is reclaimed) 1Granulose is identified its degree with C.R.Rickett report method, at last it is fed into enteric coated capsule, promptly becomes sulfation NF 1The polysaccharide intestines are used colloidal sol capsule, the just medicine of anti-AIDS always.

Claims (3)

1, a kind of Pleurotus sajor-caju NF 1Bacterial strain (Pleurotus sojorcaju), its preserving number is CGMCC No.0852, preparation sulfation NF 1Granulose, the major ingredient that it is characterized in that this polysaccharide is β-1,3 dextran, and turns to sulfation .NF through sulfuric acid 1Granulose.
2, according to the described sulfation NF of claim 1 1The preparation method of granulose is characterized in that with sucrose, Semen Maydis powder, wheat bran be culture medium inoculated NF 1Bacterial strain obtains fermented liquid through liquid submerged fermentation method, with this separate, purifying obtains NF 1Granulose changes formation sulfation NF through sulfonation reaction with this polysaccharide again 1Granulose.
3, according to the described sulfation NF of claim 1 1The application of granulose in preparation prevention and treatment AIDS-treating medicine.
CNB021485216A 2002-12-13 2002-12-13 Sulfated NF1 granulose-anti-AIDS medicine and its preparing method Expired - Fee Related CN100344747C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021485216A CN100344747C (en) 2002-12-13 2002-12-13 Sulfated NF1 granulose-anti-AIDS medicine and its preparing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021485216A CN100344747C (en) 2002-12-13 2002-12-13 Sulfated NF1 granulose-anti-AIDS medicine and its preparing method

Publications (2)

Publication Number Publication Date
CN1473926A CN1473926A (en) 2004-02-11
CN100344747C true CN100344747C (en) 2007-10-24

Family

ID=34148748

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021485216A Expired - Fee Related CN100344747C (en) 2002-12-13 2002-12-13 Sulfated NF1 granulose-anti-AIDS medicine and its preparing method

Country Status (1)

Country Link
CN (1) CN100344747C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112852640B (en) * 2021-01-13 2022-04-01 湖南农业大学 Pleurotus sajor-caju and application thereof in preparation of drugs for treating leukemia

Also Published As

Publication number Publication date
CN1473926A (en) 2004-02-11

Similar Documents

Publication Publication Date Title
CN1856568B (en) Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract
CN103725730B (en) A kind of process for refining of Hericium erinaceus (Bull. Ex Fr.) Pers. Rich in selenium mycelium polysaccharides
CN111727236A (en) Use of Rhodococcus ruber products for treating diseases caused by Candida albicans infection
CN102731365B (en) Hericium erinaceum biological micro-molecules for inhibiting helicobacter pylori and use of hericium erinaceum biological micro-molecules in treatment of digestive tract diseases
CN1082056A (en) Dextran with immunostimulatory activity
CN111803533A (en) Composition for reducing blood sugar and blood fat, preparation method and application thereof
CN110656151A (en) Method for improving kidney-tonifying and yang-strengthening effects of sea cucumber
Zhao et al. Effect of Radix isatidis polysaccharides on immunological function and expression of immune related cytokines in mice
CN108486002B (en) Momordica grosvenori endophyte strain capable of producing exopolysaccharides, method for producing exopolysaccharides and application of exopolysaccharides
CN101926828B (en) Method for extracting antibacterial substance, water soluble polysaccharide and chitin from blaps
EP0292601A1 (en) Anti aids drug extracted from lentinus edodes
CN100344747C (en) Sulfated NF1 granulose-anti-AIDS medicine and its preparing method
CN114052116B (en) Probiotic plant extract compound biological agent and preparation method and application thereof
US20020115190A1 (en) Culture of staphylococcus aureus and a method for preparing the same
CN109134682A (en) A kind of red algae oligosaccharide and the preparation method and application thereof
CN1857332A (en) Selenium-rich hedgehog fungus extract preparation for treating colitis, gastritis and stomach cancer and its preparing process
CN1331531C (en) Medicine for treating chronic gastritis
CN111789252A (en) Method for improving kidney-tonifying and yang-strengthening effects of maca by enzymolysis fermentation method
CN112079938A (en) Highland barley polysaccharide extraction method, highland barley polysaccharide extract and application thereof
CN107779404B (en) Ralstonia alba and culture method and application thereof
CN1687438A (en) Method for extracting ganoderma lucidum amylose in high germanium and ganoderma lucidum acid
CN109430527A (en) A kind of anti diar rhea feed based on low molecular weight red algae sulfated polysaccharide
CN117599095B (en) Application of harrow teeth bacteria
CN112626149B (en) Application of phellinus igniarius fermentation broth polysaccharide in anti-avian influenza virus medicine
CN114681500B (en) Porana total flavone extract and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: NANJING UNIVERSITY

Free format text: FORMER OWNER: CHEN XI

Effective date: 20050909

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20050909

Address after: 210093 No. 22, Hankou Road, Nanjing, Jiangsu

Applicant after: Nanjing University

Address before: 210008, room two, unit 45, 303 Yuan Yuan Lane, Gulou District, Jiangsu, Nanjing

Applicant before: Chen Xi

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20071024

Termination date: 20111213